HIGHLIGHTS
- who: Hasan Bayram from the National Research Institute (NRITLD), Iran Hacettepe University, Turkey have published the Article: The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort, in the Journal: (JOURNAL) of March/11,/2020
- what: The authors investigated the association of antiviral drugs including favipiravir, oseltamivir, and lopinavir/ritonavir, and HCQ and azithromycin with morbidity measures such as length of hospital stay, admission to the ICU and IMV. In the current study, lopinavir/ritonavir did not show a beneficial association with parameters studied. This study has . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.